This Article Full Text Full Text (PDF) Other Versions of this Article: AAC.01415-06v1 51/4/1327    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luque-Ortega, J. R. Articles by Rivas, L. Search for Related Content PubMed PubMed Citation Articles by Luque-Ortega, J. R. Articles by Rivas, L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2007, p. 1327-1332, Vol. 51, No. 4
0066-4804/07/$08.00+0     doi:10.1128/AAC.01415-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Miltefosine (Hexadecylphosphocholine) Inhibits Cytochrome c Oxidase in Leishmania donovani Promastigotes

Centro de Investigaciones Biológicas (C.S.I.C.), C/ Ramiro de Maeztu 9, E-28040 Madrid, Spain

Received 13 November 2006/ Returned for modification 31 December 2006/ Accepted 28 January 2007

Miltefosine (hexadecylphosphocholine [HePC]) is currently on trial as a first-choice, orally active drug for the treatment of visceral leishmaniasis when resistance to organic pentavalent antimonials becomes epidemic. However, data on the targets involved in its leishmanicidal mechanism have, until now, been only fragmentary. We have carried out a systematic study of the alterations induced on the bioenergetic metabolism of Leishmania donovani promastigotes by HePC. Overnight incubation with HePC caused a significant decline in the intracellular ATP levels of the parasites, together with a reduction in the oxygen consumption rate and mitochondrial depolarization, while the integrity of the plasma membrane remained undamaged. In a further step, the effects of HePC on the respiratory chain were addressed in digitonized parasites. The inhibition of the oxygen consumption rate caused by HePC was not reverted either with the uncoupling agent carbonyl cyanide p-trifluoromethoxyphenylhydrazone or with tetramethyl-p-phenylenediamine plus ascorbate, which feeds the electron transport chain at the level of cytochrome c. These results suggest that cytochrome c oxidase is a likely target in the complex leishmanicidal mechanism of HePC. This was further confirmed from the finding that this enzyme was specifically inhibited in a dose-dependent manner by HePC, but not the cytochrome c reductase, ruling out an unspecific effect of HePC on the respiratory chain.

Published ahead of print on 5 February 2007.

This article has been cited by other articles:

• Palit, P., Ali, N. (2008). Oral Therapy with Amlodipine and Lacidipine, 1,4-Dihydropyridine Derivatives Showing Activity against Experimental Visceral Leishmaniasis. Antimicrob. Agents Chemother. 52: 374-377 [Abstract] [Full Text]